Protein Engineering Market Size, Key Companies, Company Production Capacity, Healthcare Infrastructure Growth, Product Utilization, Regulatory Compliance, Company Expansion Strategies, Company Investment Strategies, and Market Outlook

Revenue, 2025

USD 5.09 Bn

Forecast Year, 2035

USD 23.59 Bn

CAGR, 2026 - 2035

16.57%

Report Coverage

Global

What is the Protein Engineering Market Size?

The global protein engineering market size was estimated at USD 5.09 billion in 2025 and is predicted to increase from USD 5.95 billion in 2026 to approximately USD 23.59 billion by 2035, expanding at a CAGR of 16.57% from 2026 to 2035. The protein engineering market is driven by rising demand for biologics, growing pharmaceutical research and development and increasing need for targeted therapies.

Protein Engineering Market Key Takeaways

• In terms of revenue, the market is valued at 5.09 billion in 2025.
• It is projected to reach 23.59 billion by 2035.
• The market is expected to grow at a CAGR of 16.57% from 2026 to 2035.
• North America dominated the global market with the largest market share of 41% in 2025.
• By Product, the instruments segment captured the maximum market share in 2025.
• By Technology, the rational protein design segment recorded the biggest market share in 2025.
• By Protein type, the monoclonal antibodies segment contributed to the largest market share in 2025.
• By End-user, the pharmaceutical & biotechnology companies segment generated the major market share of 43% in 2025.

Market Overview

Protein engineering is modifying or creating new ones with specific desired properties using genetic engineering techniques. The global protein engineering market has grown steadily in recent years, driven by the increasing demand for protein-based drugs, the need for more efficient and sustainable industrial processes, and the development of novel protein-based products with unique properties.

How is AI Influencing the Protein Engineering Industry?

AI is fundamentally changing the protein engineering industry by shifting the paradigm from slow, trial-and-error, computational design, wet-lab experiments to data-driven. AI prioritizes the most promising candidates for lab testing, dramatically decreasing the costly and time-intensive "trial-and-error" screening procedures. AI engineers engineer enzymes with improved thermostability and raised catalytic activity for use in harsh industrial environments, like chemical manufacturing and sustainable agriculture.

Protein Engineering Market Growth Factors

• The protein engineering market is growing due to rising use of monoclonal antibodies, vaccines and recombinant proteins. The growing demand for biologics is further driving market growth.
• Increasing prevalence of cancer, diabetes and other chronic conditions is demanding targeted protein based medicines, which creates additional opportunities in the market expansion.
• Growing investment in drug discovery and biotechnology research is expanding demand for protein engineering platforms for developing targeted therapies and other complex biological molecules.
• AI based protein modelling and generative design are helping researchers predict protein structures and reduce experimental timelines and cost. The integration of AI in protein engineering is boosting market expansion.
• The biotechnology industry is increasingly expanding as engineered enzymes are increasingly adopted in food processing, biofuels, pharmaceuticals and sustainable manufacturing to reduce energy consumption.

Market Outlook

• Industry growth overview - The protein engineering market is steadily growing as pharmaceutical companies increase investment in biologics, enzyme development and precision therapies.
• Global expansion - The North America and European markets remain dominant in the protein engineering market while the market is expanding across the Asia Pacific region.
• Major Investor - Investment is growing in AI driven protein design, synthetic biology and automated laboratory platforms. Major investors in the market include Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Agilent Technologies, and Amgen.
• Startup ecosystem - The startup ecosystem in the market is focused on developing AI protein design, computational biology and enzyme engineering.

Market Scope

Market Dynamics

Driver

Growing demand for protein-based drugs and therapeutics

The growing demand for protein-based drugs is crucial for the protein engineering market. Protein-based drugs, known as biologics, are increasingly used to treat various diseases, including cancer, autoimmune disorders, and rare genetic disorders. Compared to traditional small-molecule drugs, protein-based drugs have several advantages. They are often more selective and have fewer side effects, as they are designed to interact with specific targets in the body.

Additionally, protein-based drugs are less likely to be metabolized by the liver, which can improve their efficacy and reduce the risk of toxicity. As a result of these advantages, the global market for protein-based drugs has grown significantly. Several factors drive this growth, including the increasing prevalence of chronic diseases, ageing populations, and rising healthcare spending. In particular, the growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is driving demand for new and more effective treatments.

Adoption of personalized medicine

Personalized medicine refers to customizing medical treatment to an individual's genetic makeup or other unique characteristics, such as age, gender, and lifestyle factors. Protein engineering plays a crucial role in developing personalized medicine by enabling the creation of proteins tailored to specific patient needs.

For instance, cancer treatment often involves monoclonal antibodies targeting specific cancer cells while leaving healthy cells unharmed. Protein engineering is used to create monoclonal antibodies that are more potent and selective, improving their effectiveness and reducing side effects. Doctors enhance patient outcomes and reduce healthcare costs by developing personalized cancer treatments tailored to an individual's unique genetic profile.

The demand for protein engineering is increasing as the healthcare industry shifts towards personalized medicine. This drives growth in the protein engineering market as companies invest in research and development to create new and innovative protein-based therapeutics customized for individual patients.

Restraint

High cost of development

Protein engineering involves complex and time-consuming designing, synthesizing, and testing proteins with specific properties. This process requires significant investment in research and development, a significant barrier to entry for smaller companies and startups. In addition to the direct costs of research and development, indirect costs are associated with bringing protein-based products to market.

For instance, regulatory approval for new protein-based drugs is lengthy and expensive, involving multiple clinical trials and extensive safety testing. The high development costs associated with protein engineering limits competition in the market, as smaller companies and startup do not have the resources to invest in research and development. This leads to a concentration of market power among larger companies, limiting innovation and increasing consumer prices.

Opportunity

Advancements in gene editing and synthetic biology

Gene editing and synthetic biology technologies enable researchers to manipulate and reprogram the genetic code of cells, which can lead to the creation of novel proteins with unique properties. One promising area of research is using CRISPR/Cas9 gene editing technology to modify the genes that code for specific proteins.

By selectively editing these genes, researchers can create proteins with new or improved functions, such as increased stability, enhanced specificity, or improved activity. Synthetic biology also offers new opportunities for protein engineering. Synthetic biology involves designing and constructing new biological systems using DNA and other biological components. Researchers use synthetic biology techniques to create or modify existing proteins to perform specific functions.

For instance, researchers have used synthetic biology to engineer proteins that detect and respond to environmental stimuli, such as temperature changes or specific chemicals. These proteins could have various applications, from environmental monitoring to drug delivery. Therefore, gene editing and synthetic biology advancements are expected to drive innovation in the protein engineering market and create new and improved protein-based products with a wide range of applications in healthcare, agriculture, and industry.

Segment Insights

Product Insights

Based on product, the protein engineering market is segmented into Instruments, reagents, and software & services. In 2025, the instruments segment accounted for the largest market share. The segment's growth is due to the increasing demand for protein engineering tools and technologies in various applications such as drug discovery, biomanufacturing and biotechnology research. Advances in protein engineering techniques have led to the development of new instruments that perform more complex and precise functions.

For instance, advancements in chromatography systems have led to the development of new protein purification methods, improving the efficiency and yield of protein production. Similarly, new electrophoresis systems have enabled researchers to separate and analyze proteins more accurately and quickly. Furthermore, the increasing number of research and development activities in the biotechnology and pharmaceutical industries and the growing demand for personalized medicine are driving the need for more sophisticated instruments for protein engineering.

Technology Insights

Based on technology, the market is segmented into rational protein design, directed evolution, hybrid approach, de novo protein design, and others. In 2024, the rational protein design segment accounted for the highest market share. rational protein design is used in various applications, including drug discovery, enzyme engineering, and biocatalysis. For instance, rational protein design has been used to engineer enzymes for industrial processes, such as the production of biofuels or chemicals, as well as for medical applications, such as developing enzyme therapies for rare genetic disorders. As the field of protein engineering continues to evolve and advance, the rational protein design segment is expected to grow, driven by ongoing research and development activities and increasing demand for more specialized and effective protein-based therapeutics and industrial enzymes.

Protein Type Insights

Based on the protein type, the protein engineering market is segmented into Insulin, monoclonal antibodies, Vaccines, Colony Stimulating Factors, Coagulation Factors, and Other Proteins. In 2024, the monoclonal antibodies segment accounted for the highest market share. Monoclonal antibodies (mAbs) are laboratory-produced molecules that mimic the immune system's ability to recognize and neutralize harmful pathogens or abnormal cells. They are highly specific to their targets and are engineered to have a variety of functions.

The growth of this segment is due to several factors, including the increased understanding of the molecular mechanisms of diseases and the development of new technologies that enable the production of highly specific and effective monoclonal antibodies. The monoclonal antibodies segment is proliferating owing to a wide range of therapeutic applications for these molecules. Monoclonal antibodies are designed to target specific cells or proteins involved in disease processes, making them an attractive option for treating various cancers, autoimmune disorders, and other diseases.

Increasing demand for personalized medicine is also expected to drive segment growth. Monoclonal antibodies are engineered to target specific patient populations based on their genetic profiles or other factors, allowing for more precise and effective treatments. Moreover, the development of new technologies for the production of monoclonal antibodies has contributed to the growth of this market segment. Advances in genetic engineering and protein expression systems have made producing large quantities of highly specific monoclonal antibodies easier and more cost-effective, making them more accessible to patients.

End-User Insights

Based on the end user, the protein engineering market is segmented into Academic Research Institutes, Contract Research Organizations, and pharmaceutical & biotechnology companies. In 2025, the pharmaceutical & biotechnology companies segment held a significant market share of about 43%. This is due to major players in the protein engineering market developing and manufacturing drugs and biologics that use protein engineering technology. These companies typically have significant resources and expertise in drug discovery and development.

They conduct research or collaborate with academic research institutes or CROs to advance their understanding and develop new products. These companies invest in acquiring or licensing technology from other companies to enhance their capabilities in protein engineering. Therefore, pharmaceutical and biotechnology companies play a critical role in driving growth and innovation in the protein engineering market.

Regional Insights

What is the U.S. Protein Engineering Market Size?

The U.S. protein engineering market size was exhibited at USD 1.46 billion in 2025 and is projected to be worth around USD 6.92 billion by 2035, growing at a CAGR of 16.84% from 2026 to 2035.

In 2025, North America dominated the market holding the highest market share of about 41% owing to many biopharmaceutical and biotechnology companies and academic and research institutes specializing in protein engineering. The United States is the largest market in North America, and it is expected to continue its dominance in the coming years.

The country has a well-established biopharmaceutical industry and a strong research base, which have contributed to the growth of the protein engineering market. Furthermore, the U.S. government has increased funding for research and development in the biotechnology field, which is expected to drive the growth of the protein engineering market in the region.

Which Factors Influence the Fastest Growth of the Asia Pacific Market?

Asia Pacific is expected to grow at the fastest CAGR in the protein engineering market during the forecast period. The growth is driven by expanding biotechnology research and pharmaceutical research and development activities. Countries such as China, India, Japan, and South Korea are strengthening their capabilities in protein design by adopting biologics manufacturing, enzyme engineering and antibody development. The government in the region is supporting and investing in life science research and development. Growing CRO and CDMO activities are creating favourable conditions for market growth.

China Market Trends

China accounts for the largest share of the protein engineering market in Asia-Pacific in 2025. The growth is driven by strong biotechnology investment, expanding pharmaceutical research and increasing demand for biologic medicines. The government is supporting biotechnology and the development of domestic biopharmaceutical capabilities. The increasing investment in protein design, antibody engineering and enzyme optimization is further supporting market growth in China. The growing contract research services also contribute to the market expansion.

Which Factors Made Europe a Significantly Growing Region in the Market?

Europe is expected to grow at a considerable CAGR in the protein engineering market in the coming period. The growth is supported by established pharmaceutical companies, academic institutions and advanced laboratory infrastructure. Countries such as Germany, France and the UK remain important research and manufacturing hubs in the region. The region benefits from public funding, collaborative programs and a well developed regulatory system supporting commercialization. The region also focuses on sustainability and enzyme engineering, which supports market growth.

Germany Market Trends

Germany leads the European protein engineering market in 2025 due to its strong pharmaceutical industry, biotechnology companies and advanced manufacturing capabilities. The use of protein engineering in antibody development, enzyme optimization and industrial biotechnology further drives market expansion. Germany has well established and advanced laboratory infrastructure that supports complex protein design procedures. The collaboration between academic organizations, biotechnology companies, and pharmaceutical manufacturers supports technology development.

What are the Advancements in the Market in Latin America?

Latin America held a considerable share of the protein engineering market in 2025, supported by increasing biotechnology investment, demand for biologic medicines, and improvements in pharmaceutical research infrastructure. Brazil and Mexico are the main regional contributors because of their larger healthcare markets and pharmaceutical manufacturing bases. The region has increased local manufacturing and adoption of protein engineering, which further support the market expansion. The growing partnership between universities, research institutions and biotechnology companies is supporting market development.

Brazil Market Trends

Brazil accounts for the largest share of the Latin American protein engineering market in 2025, due to its large healthcare system, pharmaceutical industry and growing biotechnology capabilities. The government in the country is supporting research and development and promoting domestic technology adoption. Universities and public research organisations support scientific research in life sciences. Brazil's large patient population and established public health manufacturing infrastructure provide opportunities for protein based therapeutic development.

What are the Key Trends in the Market in the Middle East and Africa Region?

The Middle East & Africa held a notable share of the protein engineering market in 2025 as governments invest in healthcare infrastructure, biotechnology and advanced therapies. Gulf countries are leading regional development through healthcare modernization and economic diversification programs. The growing collaborations with universities and research institutions support market developments. The international investments in the region and partnerships with global biotechnology and pharmaceutical firms improve regional access to advanced technologies and therapies.

Saudi Arabia Market Trends

Saudi Arabia represents the leading market within the Middle East and Africa protein engineering market in 2025, supported by healthcare modernization and growing pharmaceutical and biotechnology production. The country is investing in research infrastructure, precision medicine, gene therapy, and vaccines, creating a supportive environment for protein engineering. National initiatives such as Vision 2030 support investment to target localization of pharmaceutical and biotechnology manufacturing. The rising local demand for precision medicines further supports market growth.

Value Chain Analysis for the Protein Engineering Market

• R&D: It aims to design, optimize, and even produce novel proteins and enzymes using techniques such as directed evolution, rational design, and AI-driven modeling.
  Key Players: Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, GenScript
• Clinical Trials and Regulatory Approvals: They serve as the foundational mechanism for validating safety, efficacy, and quality in the protein engineering market, changing theoretical designs into commercially viable biopharmaceuticals.
  Key Players: Merck KGaA, Agilent Technologies, Danaher Corporation
• Formulation and Final Dosage Preparation: It is a vital, science-driven process that stabilizes engineered proteins (like antibodies, enzymes, and vaccines) to ensure they remain active, stable, and even safe during manufacturing, storage, and administration.
  Key Players: Lonza Group AG, Thermo Fisher Scientific Inc., Merck KGaA

Protein Engineering Market Companies

• PerkinElmer, Inc.: PerkinElmer, Inc. provides a comprehensive suite of instruments, reagents, and even services for the protein engineering market, aiming on streamlining workflows from discovery to characterization. Their solutions mainly support biopharmaceutical research, aiming on monoclonal antibodies, enzymes, and even vaccine development.
• Waters Corp.: Waters Corporation offers a comprehensive suite of analytical instruments, specialized chemistries, and software aimed at enabling protein engineering, characterization, and therapeutic development. Their offerings aim on high-performance liquid chromatography along with mass spectrometry to determine protein structure, post-translational modifications, and stability.
• Bio-Rad Laboratories: Bio-Rad Laboratories provides a comprehensive suite of tools for the protein engineering market, aiming on antibody discovery, protein analysis, and even high-throughput screening.
• Merck KGaA: Merck KGaA provides a comprehensive portfolio for the protein engineering market, thus spanning the entire workflow from gene synthesis to antibody production, purification, and analytical characterization. Their offerings are programmed to support both research-scale and GMP-scale biopharmaceutical manufacturing.

Competitive Landscape

The protein engineering market is highly competitive and fragmented, with established pharmaceutical and biotechnology companies and emerging AI driven protein design companies. The leading companies in the market include Thermo Fisher Scientific, Merck KGaA, Danaher, Bio Rad, Agilent Technologies, Lonza, Illumina, Amgen, Regeneron Pharmaceuticals, BASF, Eppendorf, GSK plc and GenScript. Companies are strengthening their market position by product innovation and investing heavily in research and development. Strategic partnerships with pharmaceutical companies, CROs, and academic institutions can help maintain sustained market presence.

For future growth in the protein engineering market, companies should prioritize AI assisted protein design, automation, high throughput screening and scalable manufacturing.

Other Major Key Players

• Amgen, Inc.
• Agilent Technologies
• Bruker Cor.
• Thermo Fisher Scientific, Inc.
• Danaher Corp.
• GenScript Biotech Corp.

Recent Developments

• In June 2026, Merck & Co. and Protillion Biosciences launched a multi target drug discovery collaboration and license agreement potentially worth up to $520 million in milestone payments. The partnership leverages Protillion's proprietary Prot-Mao technology.
• In Jan 2022, Amgen and Generate Biomedicines announced a research collaboration agreement to discover and create protein therapeutics for five clinical targets across several therapeutic areas and multiple modalities.
• In December 2021, Insightful Science, the software company enabling the cloud for scientific discovery, announced that it had completed the transaction to acquire Protein Metrics, Inc., which is a leading provider of biopharmaceutical protein characterization and proteomics analysis software. The acquisition expands the Company's R&D value chain to widen the biopharmaceutical protein analysis arena, unblocking data analysis bottlenecks currently associated with large-scale protein studies.
• In October 2020, Agilent Technologies announced the launch of its new Agilent Seahorse XFp Analyzer, a tool for measuring metabolic activity in live cells that can be used in protein engineering research.

Segments Covered in the Report

By Product

• Instruments
• Reagents
• Software & Services

By Technology

• Rational Protein Design
• Directed Evolution
• Hybrid Approach
• De Novo Protein Design
• Others

By Protein Type

• Insulin
• Monoclonal Antibodies
• Vaccines
• Colony Stimulating Factor
• Coagulation Factors
• Other Proteins

By End-User

• Academic Research Institutes
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa